194 related articles for article (PubMed ID: 38463406)
1. Evaluating the Practicality of Causal Inference From Non-randomized Observational Data in Small-Scale Clinical Settings: A Study on the Effects of Ninjin'yoeito.
Okui N
Cureus; 2024 Mar; 16(3):e55825. PubMed ID: 38463406
[TBL] [Abstract][Full Text] [Related]
2. Ninjin'yoeito Improves Genitourinary Symptoms in Patients With Frailty.
Okui N; Okui MA
Cureus; 2023 Jun; 15(6):e40767. PubMed ID: 37363115
[TBL] [Abstract][Full Text] [Related]
3. Perspectives on the Use of Ninjin'yoeito in Modern Medicine: A Review of Randomized Controlled Trials.
Takayama S; Arita R; Ohsawa M; Kikuchi A; Yasui H; Makino T; Motoo Y; Ishii T
Evid Based Complement Alternat Med; 2019; 2019():9590260. PubMed ID: 31565066
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the severity of pre-frailty and the degree of adaptation of Ninjin'yoeito (NYT) on pre-frailty.
Amitani H; Suzuki H; Kobayashi H; Murayama M; Uto NS; Kuroda E; Kobayashi Y; Kawabe M; Amitani M; Inui A; Marunaka Y
Front Aging; 2024; 5():1304217. PubMed ID: 38681234
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic study of Ninjin'yoeito: Absorption and brain distribution of Ninjin'yoeito ingredients in mice.
Matsumoto T; Takiyama M; Sakamoto T; Kaifuchi N; Watanabe J; Takahashi Y; Setou M
J Ethnopharmacol; 2021 Oct; 279():114332. PubMed ID: 34129897
[TBL] [Abstract][Full Text] [Related]
6. Impact of Ninjin'yoeito on frailty and short life in klotho-hypomorphic (kl/kl) mice.
Amitani H; Chiba S; Amitani M; Michihara S; Takemoto R; Han L; Fujita N; Takahashi R; Inui A
Front Pharmacol; 2022; 13():973897. PubMed ID: 36353482
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of functional recovery via neurorepair mechanisms by the traditional Japanese Kampo medicine, Ninjin'yoeito, and physical exercise in a rat ischemic stroke model.
Tani A; Sakakima H; Otsuka S; Mizuno K; Nakanishi K; Norimatsu K; Takada S; Matsuoka T; Matsuzaki R; Nakakogawa T; Maruyama I
J Ethnopharmacol; 2023 Feb; 302(Pt B):115927. PubMed ID: 36402237
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of Ninjin'yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial.
Yagi T; Sawada K; Miyamoto M; Kinose Y; Nakagawa S; Takiuchi T; Kodama M; Kobayashi E; Hashimoto K; Mabuchi S; Tomimatsu T; Yoshino K; Kimura T
BMC Womens Health; 2022 Jun; 22(1):229. PubMed ID: 35701778
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of Ninjin'yoeito for Chronic Obstructive Pulmonary Disease Patients with Frailty.
Hirai K; Homma T; Matsunaga T; Akimoto K; Yamamoto S; Suganuma H; Kashima A; Sato H; Ebato T; Miyata Y; Ohta S; Inoue H; Kusumoto S; Suzuki S; Tanaka A; Sagara H
J Altern Complement Med; 2020 Aug; 26(8):750-757. PubMed ID: 32551796
[No Abstract] [Full Text] [Related]
11. Efficacy of Ninjin'yoeito in treating severe coronavirus disease 2019 in patients in an intensive care unit.
Aomatsu N; Shigemitsu K; Nakagawa H; Morooka T; Ishikawa J; Yamashita T; Tsuruoka A; Fuke A; Motoyama K; Kitagawa D; Ikeda K; Maeda K; Shirano M; Rinka H
Neuropeptides; 2021 Dec; 90():102201. PubMed ID: 34753072
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic efficacy of ninjin'yoeito for oxaliplatin-induced cumulative peripheral neuropathy in patients with colorectal cancer receiving postoperative adjuvant chemotherapy: a randomized, open-label, phase 2 trial (HOPE-2).
Motoo Y; Tomita Y; Fujita H
Int J Clin Oncol; 2020 Jun; 25(6):1123-1129. PubMed ID: 32232692
[TBL] [Abstract][Full Text] [Related]
13. Frailty Improvement by Multicomponent Drug, Ninjin'Yoeito, in Mild Cognitive Impairment and Mild Alzheimer's Disease Patients: An Open-Label Exploratory Study (FRAMINGO).
Okahara K; Ohsawa M; Haruta-Tsukamoto A; Miyoshi R; Funahashi H; Fukutani Y; Makita S; Matsuo H; Ishida Y
J Alzheimers Dis Rep; 2023; 7(1):107-117. PubMed ID: 36891253
[TBL] [Abstract][Full Text] [Related]
14. Japanese Kampo medicine ninjin'yoeito synergistically enhances tumor vaccine effects mediated by CD8
Takaku S; Shimizu M; Takahashi H
Oncol Lett; 2017 May; 13(5):3471-3478. PubMed ID: 28529575
[TBL] [Abstract][Full Text] [Related]
15. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
[TBL] [Abstract][Full Text] [Related]
16. Ninjin'yoeito suppressed the onset of arthritis, pain, and muscle atrophy in rheumatoid arthritis model mice.
Suginohara T; Kawaguchi M; Michihara S; Fujita N; Han LK; Takahashi R
Front Pharmacol; 2022; 13():974380. PubMed ID: 36601050
[TBL] [Abstract][Full Text] [Related]
17. A quasi-randomized controlled trial of Ninjin'yoeito for the treatment of postpartum anemia and the prevention of postpartum depression.
Kawakami SI; Fukuda S; Shinbori Y; Umeki M; Mitani M; Kuramoto A; Sugimoto C; Nitta M; Higashi K; Ito M
J Obstet Gynaecol Res; 2022 Nov; 48(11):2830-2838. PubMed ID: 35882511
[TBL] [Abstract][Full Text] [Related]
18. Ninjin'yoeito, a traditional Japanese medicine, attenuates age-related deficits of muscle performance, self-care motivation, and body temperature in C57BL/6 mice.
Matsubara Y; Miyama Y; Imai R; Oizumi H; Miyazaki S; Haneda E; Mizuno K; Omiya Y; Ikeda Y; Mizoguchi K
Biosci Biotechnol Biochem; 2022 Jun; 86(7):895-901. PubMed ID: 35396846
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the usefulness of Ninjin'yoeito Kampo medicine in combination with rehabilitation therapy in patients with frailty complicated by intractable dizziness.
Arai M
Neuropeptides; 2021 Dec; 90():102189. PubMed ID: 34481223
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study on the efficacy of Ninjin'yoeito on fatigue in patients with interstitial pneumonia.
Kushima H; Kinoshita Y; Fujita M; Ishii H
Neuropeptides; 2021 Oct; 89():102178. PubMed ID: 34298370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
